Evidence map›Paper›PMID 38403044›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2024

Expanding the repertoire of

René R Sevag Packard

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

René R Sevag PackardDivision of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA; Department of Physiology, David Geffen School of Medicine, University of California, Los Angeles, USA; Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA; Veterans Affairs West Los Angeles Medical Center, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, USA; Molecular Biology Institute, University of California, Los Angeles, USA; California NanoSystems Institute, University of California, Los Angeles, USA. Electronic address: rpackard@mednet.ucla.edu.

Funding

Dissecting mechanisms of anthracycline-induced cardiotoxicityR56HL158569 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PACKARD, RENE R.S. · 2022 to 2022
$390k
Integrating 3-D Intravascular Sensors with Fractional Flow Reserve for Lipid-Rich PlaquesI01BX004558 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI PACKARD, RENE R.S. · 2020 to 2023
–
BLRD VA I01 BX004558NHLBI NIH HHS R56 HL158569
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fluorine RadioisotopesRadiopharmaceuticalsHumansPositron-Emission TomographyFluorine RadioisotopesRadiopharmaceuticals

Identifiers

PMID38403044
PMCPMC11717124

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.